Oral complications of cancer and cancer therapy

  title={Oral complications of cancer and cancer therapy},
  author={Joel B. Epstein and Juliette Thariat and Ren{\'e}-Jean Bensadoun and Andrei Barasch and Barbara A. Murphy and Leanne Kolnick and Leslie L Popplewell and Ellie G. Maghami},
  journal={CA: A Cancer Journal for Clinicians},
Answer questions and earn CME/CNE 

A multicenter retrospective investigation on the efficacy of perioperative oral management in cancer patients

This research presents a novel probabilistic procedure called “spot-spot analysis” that allows for real-time analysis of the response of the immune system to foreign substance abuse.

Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.

This manuscript focuses on the NCCN Guidelines Panel recommendations for the workup, primary treatment, risk reduction strategies, and surveillance specific to DCIS.

Epithelial-mesenchymal transition related to bone invasion in oral squamous cell carcinoma

Oral surgery in patients undergoing chemoradiation therapy.

Impact of Pain and Evaluation of Education and Self-Care in Patients with Head and Neck Cancer

It is not unusual for patients with head and neck cancer (HNC) to suffer from both tumor and treatment-related pain that is difficult to alleviate despite individualized pharmacological treatment.T

Efficacy of Aloe Vera Gel Topical Application on Radiation Induced Mucositis in Head and Neck Malignancy

The treatment of HNM has undergone a gradual evolution over the past 3 decades, with an increased emphasis placed on organ preservation and multimodality management, including the use of radiotherapy and chemotherapy.

Procedure in the prevention and nurturing of inflammatory changes of oral mucositis among patients treated for oncological conditions

Oral mucositis is a serious complication occurring in the process of chemotherapy and/or radiotherapy, which, consequently, may have an impact on oncological treatment.

Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.

Supportive care recommendations in the NCCN Guidelines for Head and Neck Cancers are described, as well as the rationale supporting a new section on imaging recommendations for patients with H&N cancers.

Cannabidiol: an alternative therapeutic agent for oral mucositis?

The literature on the etiopathogenesis of oral mucositis and the activity of cannabidiol is reviewed, to consider the possibility of its use for the prevention and treatment of Oral mucosiositis.

Pathogenesis and Amelioration of Radiation-Induced Oral Mucositis

This review presents a pathophysiological-based review of prevention techniques available for reducing the incidence and duration of severe OM and concludes that familiarity of the physician with the available preventative measures and patient preference in accepting which strategies for OM amelioration are used are important.



Taste dysfunction in patients receiving radiotherapy

Taste loss is a major cause of morbidity in patients undergoing head and neck irradiation and should be considered when deciding whether or not to proceed with surgery.

Perspectives on cancer therapy‐induced mucosal injury

An international multidisciplinary panel of experts assembled to create clinical practice guidelines for the prevention, evaluation, and treatment of mucositis.

Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma

The current study was conducted to characterize the risks and clinical consequences of oral mucositis (OM) in patients with head and neck carcinoma (HNC) who are receiving radiation therapy.

Measuring Comorbidity in Patients With Head and Neck Cancer

Comorbidities are diseases or conditions that coexist with a disease of interest that can alter treatment decisions, change resource utilization, and confound the results of survival analysis.

Transoral robotic resection and reconstruction for head and neck cancer

To evaluate the patterns of failure, survival, and functional outcomes for patients treated with transoral robotic surgery (TORS) and compare these results with those from a cohort of patients treating with concurrent chemoradiation (CRT), a large number of patients are treated with TORS.

Phase III randomized study: Oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation‐induced xerostomia

Xerostomia is a serious morbidity of radiation treatment in head and neck cancer and should not be taken as a cause for concern.

Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: A report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis

The National Cancer Institute of Canada Clinical Trials Group undertook a multicenter, randomized, double‐blind controlled trial of an oral antimicrobial versus placebo to prevent and treat

Long‐Term Quality of Life of Patients With Head and Neck Cancer

Objectives: To describe prospectively the long‐term changes of quality of life and mood in patients with squamous cell carcinoma of the head and neck treated with surgery and/or radiotherapy.

NCCN Task Force Report. prevention and management of mucositis in cancer care.

This report integrates expert judgment with a review of key literature on risk assessment, prevention, and treatment strategies, and provides recommendations for the overall management of oral mucositis.

A prospective, longitudinal study of pain in head and neck cancer patients

The epidemiology of pain in head and neck cancer, the effects of curative treatment on this pain, and the impact that pain experience may have on patients' quality of life (QL) are studied.